Document Detail


Increased anticoagulant osmolality improves separation of leukocytes from red blood cells (RBC).
MedLine Citation:
PMID:  10848439     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The bottom-and-top (BAT) procedure separates the buffy coat (BC) from plasma and red blood cells (RBC). The contents of mononuclear cells (MNC) remaining in the RBC are about 1 x 10(6) cells/unit, whereas the granulocytes are removed less effectively, 500-800 x 10(6) or more remaining in the RBC unit. The aim was to improve the separation efficacy by collecting the blood in an hyperosmolar anticoagulant, followed by BAT separation. It was expected that the red cells would shrink, thereby increasing their density, while the granulocytes would not change volume and density. STUDY DESIGN AND METHODS: 18 donors were included in the study, 12 in the test group and 6 in the control group. CPD-SAGM bags were used, with a modification of the anticoagulant by removal of 20-ml CPD from all units and addition of 20-ml mannitol (test group) or 20 ml of isotonic saline (control group). The collected blood units were cooled on butanediol plates for 2-4 h, then centrifuged and separated into components. The levels of leukocytes in the whole blood, the BC and the RBC were determined by flow cytometry gated for intact CD45+ cells. A number of other tests were performed during 42-day storage. RESULTS: The plasma yield was slightly higher in the test group than in the control group (ns). The contents of leukocytes (CD 45+ intact cells) in the RBC units were 32 +/- 20 x 10(6) in the test group and 573 +/- 241 x 10(6) in the control group. The numbers of MNC were 1.2 +/- 0.6 x 10(6) and 2.6 +/- 1.8 x 10(6), respectively. The RBC 2,3-DPG concentration was slightly better maintained in the test group at day 7 of refrigerated storage (p = 0.0027), but most other tested parameters showed no difference during 42-day storage. It was possible to prepare platelet concentrates with good yield using the pooled-BC method. CONCLUSION: This study indicates that considerable improvement in the BAT procedure can be obtained if the anticoagulant is made hypertonic by the addition of mannitol. This is achieved without altering the already low levels of MNC and keeping the same quality.
Authors:
F Knutson; H Lööf; C F Högman
Related Documents :
2672179 - Blood donation and hiv infection: impact of seroconversion delay on the sensitivity of ...
7812349 - Evaluation of a new test for colorectal neoplasms: a prospective study of asymptomatic ...
6605779 - Self-reported dark red bleeding as a marker comparable with occult blood testing in scr...
7195139 - Prediction of the severity of abo haemolytic disease of the newborn by cord blood tests.
20535659 - Blood testing in sport: hematological profiling.
21471849 - Pharmacology in nuclear cardiology.
6391149 - Detection of bacteriuria by leukocyte esterase, nitrite, and the automicrobic system.
3309649 - Effect of bacterial growth-inhibiting ingredients on the ames mutagenicity of medicinal...
16738459 - Development of an unsupported arm exercise test in patients with chronic obstructive pu...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Transfusion science     Volume:  21     ISSN:  0955-3886     ISO Abbreviation:  Transfus Sci     Publication Date:  1999 Dec 
Date Detail:
Created Date:  2000-05-18     Completed Date:  2000-05-18     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9001514     Medline TA:  Transfus Sci     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  185-91     Citation Subset:  T    
Affiliation:
Department of Clinical Immunology and Transfusion Medicine, University Hospital, Uppsala, Sweden. folke.knutson@klinimm.uu.se
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anticoagulants / chemistry*
Blood Component Removal / methods*,  standards
Cell Separation / methods*,  standards
Erythrocytes*
Granulocytes
Humans
Leukocytes*
Mannitol / pharmacology
Osmolar Concentration
Sodium Chloride / pharmacology
Chemical
Reg. No./Substance:
0/Anticoagulants; 69-65-8/Mannitol; 7647-14-5/Sodium Chloride

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A point-of-care analyzer for blood gases, Chem 7, Hct, and Hgb.
Next Document:  Cascade filtration for TTP: an effective alternative to plasma exchange with cryodepleted plasma.